Boston Scientific Supports Trial to Evaluate Platinum Chromium Coronary Stents RTT News (BSX: News ) announced its support of the HORIZONS II AMI clinical trial, which is designed to evaluate the safety and efficacy of the PROMUS Element Plus Everolimus-Eluting Platinum Chromium Coronary Stent compared to the OMEGA Platinum Chromium ... Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium ... Landmark Analysis of Year Two Data From PLATINUM Workhorse Trial Demonstrates ... Analysis of Two Randomized Clinical Trials Identify No Cases of Longitudinal ... |
